Correct Capital Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Correct Capital Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-358	Closed	-$207K	–	117
2025 Q4	$207K	Buy	+358	New	+$202K	0.04%	109
2025 Q2	–	Sell	-432	Closed	-$215K	–	118
2025 Q1	$215K	Sell	432 -205	-32%	-$111K	0.03%	108
2024 Q4	$331K	Hold	637	–	–	0.07%	94
2024 Q3	$394K	Buy	637 +197	+45%	+$117K	0.09%	93
2024 Q2	$243K	Hold	440	–	–	0.06%	107
2024 Q1	$256K	Buy	440 +27	+7%	+$15.2K	0.06%	119
2023 Q4	$219K	Buy	+413	New	+$200K	0.06%	116

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Correct Capital Wealth Management's TMO Position: Q1 2026 in Review

Correct Capital Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 358 shares — an estimated $207K sold.

Correct Capital Wealth Management first reported a position in TMO in Q4 2023 and held it in 7 quarters. The position peaked at $394K in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Correct Capital Wealth Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Correct Capital Wealth Management sold 358 Thermo Fisher Scientific shares in Q1 2026, an estimated $207K.
Correct Capital Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 7 quarters.
Correct Capital Wealth Management's Thermo Fisher Scientific position peaked at $394K in Q3 2024.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Correct Capital Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.